Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using a sustained release depot formulation comprising glatiramer acetate

Method for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using a sustained release depot formulation comprising glatiramer acetate

US Patent 12343371 · Granted Jul 1, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Depot systems comprising glatiramer acetate2025
Depot systems comprising glatiramer acetate2025
Depot systems comprising glatiramer acetate2025
Depot systems comprising cariprazine or salts thereof2025
Depot systems comprising glatiramer or pharmacologically acceptable salt thereof2025
Treatment of inflammatory bowel disease with long acting glatiramer and adipose-2024
Treatment of inflammatory bowel disease with long acting glatiramer and adipose-2024
Process for preparing microparticles containing glatiramer acetate2024
Process for preparing microparticles containing glatiramer acetate2024
Depot systems comprising Cariprazine or salts thereof2024
Semaglutide depot systems and use thereof2024
Semaglutide depot systems and use thereof2024